ArticleJournal of hematology & oncology2016

High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide.

Maryam Pourabdollah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.